INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 52 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,380,328 | +46.0% | 3,384,000 | +45.7% | 0.01% | +40.0% |
| Q4 2022 | $2,315,739 | +23.5% | 2,323,000 | +21.6% | 0.01% | +25.0% |
| Q3 2022 | $1,875,000 | +18.7% | 1,910,000 | +20.1% | 0.00% | +33.3% |
| Q2 2022 | $1,579,000 | +10.2% | 1,590,000 | +3.0% | 0.00% | +50.0% |
| Q1 2022 | $1,433,000 | -1.2% | 1,543,000 | +2.5% | 0.00% | 0.0% |
| Q4 2021 | $1,451,000 | -10.0% | 1,506,000 | -25.0% | 0.00% | -33.3% |
| Q3 2020 | $1,613,000 | -42.9% | 2,007,000 | -46.5% | 0.00% | -50.0% |
| Q2 2020 | $2,823,000 | +113.9% | 3,752,000 | +127.4% | 0.01% | +100.0% |
| Q1 2020 | $1,320,000 | +52.6% | 1,650,000 | +92.3% | 0.00% | +50.0% |
| Q4 2019 | $865,000 | +291.4% | 858,000 | +284.8% | 0.00% | – |
| Q1 2019 | $221,000 | -27.1% | 223,000 | -32.2% | 0.00% | -100.0% |
| Q4 2018 | $303,000 | -55.8% | 329,000 | -51.5% | 0.00% | 0.0% |
| Q3 2018 | $686,000 | -32.7% | 679,000 | -41.7% | 0.00% | -50.0% |
| Q2 2018 | $1,019,000 | -42.2% | 1,164,000 | -47.1% | 0.00% | -33.3% |
| Q1 2018 | $1,763,000 | +129.9% | 2,200,000 | +131.6% | 0.00% | +200.0% |
| Q4 2017 | $767,000 | +35.5% | 950,000 | +30.1% | 0.00% | 0.0% |
| Q3 2017 | $566,000 | -20.5% | 730,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $712,000 | -2.3% | 730,000 | -6.4% | 0.00% | 0.0% |
| Q1 2017 | $729,000 | +4.1% | 780,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $700,000 | – | 780,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERBACK ASSET MANAGEMENT LLC | 12,851,000 | $12,016,000 | 2.95% |
| Context Capital Management, LLC | 3,000,000 | $2,804,000 | 2.24% |
| Man Investments (CH) AG | 3,000,000 | $2,798,000 | 1.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 42,500,000 | $39,540,000 | 1.52% |
| MACKAY SHIELDS LLC | 17,069,000 | $15,982,000 | 0.73% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 73,035,000 | $68,425,000 | 0.63% |
| WOLVERINE ASSET MANAGEMENT LLC | 42,307,000 | $39,554,000 | 0.61% |
| LINDEN ADVISORS LP | 14,122,000 | $13,194,000 | 0.49% |
| GLG LLC | 9,100,000 | $8,486,000 | 0.47% |
| Jabre Capital Partners S.A. | 3,400,000 | $3,179,000 | 0.38% |